Literature DB >> 23165428

The psychosis high-risk state: a comprehensive state-of-the-art review.

Paolo Fusar-Poli1, Stefan Borgwardt, Andreas Bechdolf, Jean Addington, Anita Riecher-Rössler, Frauke Schultze-Lutter, Matcheri Keshavan, Stephen Wood, Stephan Ruhrmann, Larry J Seidman, Lucia Valmaggia, Tyrone Cannon, Eva Velthorst, Lieuwe De Haan, Barbara Cornblatt, Ilaria Bonoldi, Max Birchwood, Thomas McGlashan, William Carpenter, Patrick McGorry, Joachim Klosterkötter, Philip McGuire, Alison Yung.   

Abstract

CONTEXT: During the past 2 decades, a major transition in the clinical characterization of psychotic disorders has occurred. The construct of a clinical high-risk (HR) state for psychosis has evolved to capture the prepsychotic phase, describing people presenting with potentially prodromal symptoms. The importance of this HR state has been increasingly recognized to such an extent that a new syndrome is being considered as a diagnostic category in the DSM-5.
OBJECTIVE: To reframe the HR state in a comprehensive state-of-the-art review on the progress that has been made while also recognizing the challenges that remain. DATA SOURCES: Available HR research of the past 20 years from PubMed, books, meetings, abstracts, and international conferences. STUDY SELECTION AND DATA EXTRACTION: Critical review of HR studies addressing historical development, inclusion criteria, epidemiologic research, transition criteria, outcomes, clinical and functional characteristics, neurocognition, neuroimaging, predictors of psychosis development, treatment trials, socioeconomic aspects, nosography, and future challenges in the field. DATA SYNTHESIS: Relevant articles retrieved in the literature search were discussed by a large group of leading worldwide experts in the field. The core results are presented after consensus and are summarized in illustrative tables and figures.
CONCLUSIONS: The relatively new field of HR research in psychosis is exciting. It has the potential to shed light on the development of major psychotic disorders and to alter their course. It also provides a rationale for service provision to those in need of help who could not previously access it and the possibility of changing trajectories for those with vulnerability to psychotic illnesses.

Entities:  

Mesh:

Year:  2013        PMID: 23165428      PMCID: PMC4356506          DOI: 10.1001/jamapsychiatry.2013.269

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  150 in total

1.  Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study.

Authors:  Ian Kelleher; Aileen Murtagh; Charlene Molloy; Sarah Roddy; Mary C Clarke; Michelle Harley; Mary Cannon
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

2.  EEG spectral power and negative symptoms in at-risk individuals predict transition to psychosis.

Authors:  Ronan Zimmermann; Ute Gschwandtner; Frank H Wilhelm; Marlon O Pflueger; Anita Riecher-Rössler; Peter Fuhr
Journal:  Schizophr Res       Date:  2010-09-20       Impact factor: 4.939

3.  What percentage of people in the general population satisfies the current clinical at-risk criteria of psychosis?

Authors:  Benno G Schimmelmann; Chantal Michel; Noemi Schaffner; Frauke Schultze-Lutter
Journal:  Schizophr Res       Date:  2010-10-30       Impact factor: 4.939

4.  Integrating the negative psychotic symptoms in the high risk criteria for the prediction of psychosis.

Authors:  P Fusar-Poli; S Borgwardt
Journal:  Med Hypotheses       Date:  2007-03-01       Impact factor: 1.538

5.  Recruitment and treatment practices for help-seeking "prodromal" patients.

Authors:  Thomas H McGlashan; Jean Addington; Tyrone Cannon; Markus Heinimaa; Patrick McGorry; Mary O'Brien; David Penn; Diana Perkins; Raimo K R Salokangas; Barbara Walsh; Scott W Woods; Alison Yung
Journal:  Schizophr Bull       Date:  2007-05-04       Impact factor: 9.306

6.  Prevalence of suicide risk factors in people at ultra-high risk of developing psychosis: a service audit.

Authors:  Paul Hutton; Samantha Bowe; Sophie Parker; Sarah Ford
Journal:  Early Interv Psychiatry       Date:  2011-11       Impact factor: 2.732

7.  Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies.

Authors:  Paolo Fusar-Poli; Joaquim Radua; Philip McGuire; Stefan Borgwardt
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

8.  A risk factor screening and assessment protocol for schizophrenia and related psychosis.

Authors:  V Carr; S Halpin; N Lau; S O'Brien; J Beckmann; T Lewin
Journal:  Aust N Z J Psychiatry       Date:  2000-11       Impact factor: 5.744

9.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

10.  The reliability of DSM-III prodromal symptoms in first-episode psychotic patients.

Authors:  H J Jackson; P D McGorry; D McKenzie
Journal:  Acta Psychiatr Scand       Date:  1994-11       Impact factor: 6.392

View more
  396 in total

1.  At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction.

Authors:  Paolo Fusar-Poli; Marco Cappucciati; Grazia Rutigliano; Frauke Schultze-Lutter; Ilaria Bonoldi; Stefan Borgwardt; Anita Riecher-Rössler; Jean Addington; Diana Perkins; Scott W Woods; Thomas H McGlashan; Jimmy Lee; Joachim Klosterkötter; Alison R Yung; Philip McGuire
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

2.  [Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Con].

Authors:  A Bechdolf; S Laier; M Kallenbach; A Biester; K Leopold
Journal:  Nervenarzt       Date:  2015-11       Impact factor: 1.214

3.  Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.

Authors:  Jadon R Webb; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert K Heinssen; Larry J Seidman; Sarah I Tarbox; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Scott W Woods
Journal:  Schizophr Bull       Date:  2015-09       Impact factor: 9.306

4.  Clinical high risk for psychosis in childhood and adolescence: findings from the 2-year follow-up of the ReARMS project.

Authors:  Michele Poletti; Lorenzo Pelizza; Silvia Azzali; Federica Paterlini; Sara Garlassi; Ilaria Scazza; Luigi Rocco Chiri; Eva Gebhardt; Simona Pupo; Raballo Andrea
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-12-01       Impact factor: 4.785

5.  Attenuated Mismatch Negativity in Attenuated Psychosis Syndrome Predicts Psychosis: Can Galantamine-Memantine Combination Prevent Psychosis?

Authors:  Maju Mathew Koola
Journal:  Mol Neuropsychiatry       Date:  2018-06-07

Review 6.  Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.

Authors:  Christin Schifani; Sina Hafizi; Tania Da Silva; Jeremy Joseph Watts; M Saad Khan; Romina Mizrahi
Journal:  Int Rev Psychiatry       Date:  2017-12-08

7.  Cortical Volume Differences in Subjects at Risk for Psychosis Are Driven by Surface Area.

Authors:  Roman Buechler; Diana Wotruba; Lars Michels; Anastasia Theodoridou; Sibylle Metzler; Susanne Walitza; Jürgen Hänggi; Spyros Kollias; Wulf Rössler; Karsten Heekeren
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

8.  Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.

Authors:  Eva Velthorst; Eric C Meyer; Anthony J Giuliano; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Larry J Seidman
Journal:  Schizophr Res       Date:  2018-08-02       Impact factor: 4.939

9.  North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.

Authors:  Jean Addington; Lu Liu; Lisa Buchy; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Thomas H McGlashan
Journal:  J Nerv Ment Dis       Date:  2015-05       Impact factor: 2.254

10.  Coping Strategies Mediate the Effect of Stressful Life Events on Schizotypal Traits and Psychotic Symptoms in 22q11.2 Deletion Syndrome.

Authors:  Marco Armando; Corrado Sandini; Maelle Chambaz; Marie Schaer; Maude Schneider; Stephan Eliez
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.